Bath Psoriatic Arthritis Biobank (Renewal 2023)
Research type
Research Tissue Bank
IRAS ID
338034
Contact name
Charlotte Cavill
Contact email
Research summary
The Bath Psoriatic Arthritis Biobank
REC name
South West - Central Bristol Research Ethics Committee
REC reference
24/SW/0018
Date of REC Opinion
5 Apr 2024
REC opinion
Further Information Favourable Opinion
Data collection arrangements
Demographic information (including GP details, ethnicity, age, education,employment, gender)
Clinical assessments (including symptoms, other diagnosis, x-rays, MRI, past medical history, medications, disease activity, symptom onset)
Family history
Blood samples (Serum / DNA / Plasma)
Patient reported questionnaires (including pain, fatigue, work, comorbidity and quality of life and exercise)
Additional health risks (fractures and osteoporosis etc), and other relevant clinical information (including previous treatment).
Informed consent will be taken in writing and stored in secure research facility and in patients' notes.
Research programme
Patients with Psoriatic Arthritis can develop profound symptoms in their joints, tendons, skin, nails and spine, that may limit mobility and quality of life. We would like to better understand why some patients develop these specific manifestations and have a worse prognosis, while others do not and have a relatively mild disease course. Using blood biomarkers is a promising way of learning more about the disease process.
RTBTitle
The Bath Psoriatic Arthritis Biobank
Establishment organisation
Research and Development (D1), Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust
Establishment organisation address
Combe Park
Bath
BA1 3NG